Corcept Therapeutics
CORT
#3229
Rank
NZ$8.34 B
Marketcap
NZ$78.44
Share price
5.00%
Change (1 day)
-25.18%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2025 (TTM): NZ$1.60

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$1.60. In 2024 the company made an earnings per share (EPS) of NZ$2.29.

EPS history for Corcept Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.60-30.18%
2024NZ$2.29
2022NZ$1.61-2.06%
2021NZ$1.655.43%
2020NZ$1.5610.84%
2019NZ$1.4127.69%
2018NZ$1.10-42.48%
2017NZ$1.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.93 1,084.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.23 665.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31 44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.12 2,349.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.42 677.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.88 268.09%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.17-89.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.85-153.19%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$3.09 93.62%๐Ÿ‡บ๐Ÿ‡ธ USA